ARCHIVES

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

This article is from The Cancer Letter archive.

Vol. 03 No. 50 | December 16, 1977

Download PDF Visit The Full Archive

Related Articles

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB.

October 8, 2004

Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers

August 7, 1998

In Brief: Sondik is Acting NCI Deputy Director; $21 mil. Gift Supports Univ. Of Chicago

March 4, 1994

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

July 9, 1999

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010